Description: Pharmacy continues to be one of, if not the, fastest growing services in both public and private health plans. Between new blockbuster drugs and gene therapies coming to the market at a record pace expanded indications for drugs already on the market, and rapid cost inflation across numerous therapeutic categories, plan sponsors are constantly looking for new and innovative ways to keep pharmacy costs under control.

Description: The objective of this session is to explore the fast-growing segment of healthcare that is provider enablement. Value-based care (VBC) in its original form was an alignment between providers and payers to deliver on the triple aim of cost of care, experience of care, and health of populations (more recently the quintuple aim including health equity and provider experience).

Description: This session will provide an overview of the challenges found in understanding and managing the medical drug benefit based on standard claims data. Participants will learn what makes coding medical drugs challenging and how to navigate some of the pitfalls when conducting analyses on this important segment of utilization and cost trend.

Description: Come learn how Maryland is leading the charge in improving affordability for its individual market enrollees. Learn about the success of the state's 1332 reinsurance program and additional initiatives including further Medicaid expansion, additional state and CSR subsidies, and eligible population expansions.

Description: Get highlights from recently published and upcoming research from the SOA Research Institute, including work on specialty pharmacy and 'Valuing the Impact of Technology in Health Care'. Presenters will focus on the financial impacts of these issues as well as trends and other actuarial considerations.

Description: This session will explore the financial health of rural hospitals, especially as it relates to the impact of payer cost containment strategies and government policies. Since 2005, more than 100 rural hospitals have closed and 600 more are at risk.

Description: How do social determinants of health (SDOH) affect health outcomes in the United States, how might SDOH factors be incorporated into financing and risk adjustment of Medicaid, and what implications might this have for market participants?

Description: Virtual - Session 6A: The ROI of Wellness - Actuarial Insights on Digital Health Engagement

Description: Virtual - Session 2D: Navigating Risk Management in Gender - Affirming Care

Description: Virtual - Session 3B: Medicare Supplement – Market and Opportunity